• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Suzuki Toshihiro  鈴木 利宙

ORCIDConnect your ORCID iD *help
Researcher Number 50530135
Other IDs
Affiliation (Current) 2025: 国立研究開発法人国立がん研究センター, 先端医療開発センター, 研究員
Affiliation (based on the past Project Information) *help 2024 – 2025: 国立研究開発法人国立がん研究センター, 先端医療開発センター, 研究員
2021 – 2023: 帝京大学, 医学部, 助教
2020: 帝京大学, 公私立大学の部局等, 助教
2019: 帝京大学, 公私立大学の部局等, 講師
2018: 国立研究開発法人国立がん研究センター, 先端医療開発センター, 特任研究員
Review Section/Research Field
Principal Investigator
Basic Section 50010:Tumor biology-related / Basic Section 55020:Digestive surgery-related
Except Principal Investigator
Basic Section 49020:Human pathology-related / Medium-sized Section 90:Biomedical engineering and related fields / Basic Section 54010:Hematology and medical oncology-related
Keywords
Principal Investigator
腫瘍応答性T細胞 / 個別化がん免疫療法 / 腫瘍内免疫環境 / ネオアンチゲン予測パイプライン / TCR遺伝子決定 / 自己腫瘍反応性の評価 / 肝胆膵領域がん / TCR導入T細胞療法 / 遺伝子治療 / 遺伝子マーカー … More / トランスクリプトーム解析 / TCR再構築 / グリピカン3 / TCR遺伝子 / 腫瘍内浸潤T細胞 / 共通がん抗原 / TCR遺伝子導入T細胞 / 非ウイルス性肝細胞がん / 自己腫瘍反応性 / ネオアンチゲン / がん抗原 / TCR導入T細胞 / 疲弊化機構 / シングル細胞解析 / 腫瘍浸潤T細胞 … More
Except Principal Investigator
紡錘形細胞がん / 未分化がん / 肉腫様がん / Cas9 / polymeric micelles / Endosome escape / Cathepsin B / KRAS / Cancer / Gene editing / チロシンリン酸化シグナル / オルガネラ / 細胞内分子イメージング / 細胞内輸送阻害剤 / 分子標的薬 / FLT3-ITD / 変異型チロシンキナーゼ / FLT3 / 細胞内局在 / FLT3変異 / 急性骨髄性白血病 Less
  • Research Projects

    (5 results)
  • Research Products

    (18 results)
  • Co-Researchers

    (9 People)
  •  ヒト肝がんにおけるがん反応性組織常在メモリーT細胞の腫瘍内活性化制御機構の解明Principal Investigator

    • Principal Investigator
      鈴木 利宙
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      National Cancer Center Japan
  •  Construction of the sarcomatoid carcinoma concept and pathological investigation

    • Principal Investigator
      小嶋 基寛
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 49020:Human pathology-related
    • Research Institution
      National Cancer Center Japan
  •  Development of Innovative Cancer Genome Editing Therapy Using Polymeric Micelles Implementing High Precision Intracellular Delivery Function

    • Principal Investigator
      Cabral Horacio
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Review Section
      Medium-sized Section 90:Biomedical engineering and related fields
    • Research Institution
      The University of Tokyo
  •  Understanding the organelle signaling of mutant FLT3 in Acute Myeloid Leukemia (AML) to develop novel therapeutic tactics

    • Principal Investigator
      Abe Ryo
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Teikyo University
  •  Identification and application of tumor reactive T cells in hepatobiliary and pancreatic cancers to personalized cancer immunotherapyPrincipal Investigator

    • Principal Investigator
      Suzuki Toshihiro
    • Project Period (FY)
      2018 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55020:Digestive surgery-related
    • Research Institution
      Teikyo University
      National Cancer Center Japan

All 2022 2021 2020 2019 2018 Other

All Journal Article Presentation Other

  • [Journal Article] Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis2022

    • Author(s)
      Yagi Naoki、Suzuki Toshihiro、Mizuno Shoichi、Kojima Motohiro、Kudo Masashi、Sugimoto Motokazu、Kobayashi Shin、Gotohda Naoto、Ishii Genichiro、Nakatsura Tetsuya
    • Journal Title

      Cancer Science

      Volume: 113 Issue: 5 Pages: 1564-1574

    • DOI

      10.1111/cas.15313

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] ネオアンチゲンとがん免疫2022

    • Author(s)
      鈴木 利宙、藤浪 紀洋、下村 真菜美、Charneau Jimmy、平糠 和志、 山田 崇、三嶋 雄二、渡部 典子、中村 徳弘、中面 哲也
    • Journal Title

      腫瘍内科

      Volume: 29(2) Pages: 213-219

    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse2022

    • Author(s)
      Charneau Jimmy、Suzuki Toshihiro、Shimomura Manami、Fujinami Norihiro、Mishima Yuji、Hiranuka Kazushi、Watanabe Noriko、Yamada Takashi、Nakamura Norihiro、Nakatsura Tetsuya
    • Journal Title

      Cancer Science

      Volume: 113 Issue: 4 Pages: 1113-1124

    • DOI

      10.1111/cas.15291

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses2021

    • Author(s)
      Morisue Ryo、Kojima Motohiro、Suzuki Toshihiro、Nakatsura Tetsuya、Ojima Hidenori、Watanabe Reiko、Sugimoto Motokazu、Kobayashi Shin、Takahashi Shinichiro、Konishi Masaru、Ishii Genichiro、Gotohda Naoto、Fujiwara Toshiyoshi、Ochiai Atsushi
    • Journal Title

      International Journal of Cancer

      Volume: - Issue: 3 Pages: 546-560

    • DOI

      10.1002/ijc.33545

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.2021

    • Author(s)
      Oka M, Xu L, Suzuki T, Yoshikawa T, Sakamoto H, Uemura H, Yoshizawa AC, Suzuki Y, Nakatsura T, Ishihama Y, Suzuki A, Seki M
    • Journal Title

      Genome Biol.

      Volume: 22(1):9 Issue: 1 Pages: 1-9

    • DOI

      10.1186/s13059-020-02240-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09297, KAKENHI-PLANNED-17H06306, KAKENHI-PROJECT-19K16108, KAKENHI-PROJECT-19K16792, KAKENHI-PROJECT-16H06279, KAKENHI-PROJECT-18K08637, KAKENHI-ORGANIZER-17H06299
  • [Journal Article] FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cells2021

    • Author(s)
      Yamawaki Kouhei、Shiina Isamu、Murata Takatsugu、Tateyama Satoru、Maekawa Yutarou、Niwa Mariko、Shimonaka Motoyuki、Okamoto Koji、Suzuki Toshihiro、Nishida Toshirou、Abe Ryo、Obata Yuuki
    • Journal Title

      BioRxiv

      Volume: -

    • DOI

      10.1101/2021.01.01.424454

    • Open Access
    • Data Source
      KAKENHI-PROJECT-20K08719, KAKENHI-PROJECT-18K07208
  • [Journal Article] Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances2021

    • Author(s)
      Charneau Jimmy、Suzuki Toshihiro、Shimomura Manami、Fujinami Norihiro、Nakatsura Tetsuya
    • Journal Title

      Journal of Hepatocellular Carcinoma

      Volume: Volume 8 Pages: 1035-1054

    • DOI

      10.2147/jhc.s291558

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma2019

    • Author(s)
      Akazawa Y, Suzuki T, Yoshikawa T, Mizuno S, Nakamoto Y, and Nakatsura T
    • Journal Title

      World J Metaanal.

      Volume: 7 Issue: 3 Pages: 80-95

    • DOI

      10.13105/wjma.v7.i3.80

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification.2018

    • Author(s)
      Takahashi D, Kojima M, Suzuki T, Sugimoto M, Kobayashi S, Takahashi S, Konishi M, Gotohda N, Ikeda M, Nakatsura T, Ochiai A, Nagino M.
    • Journal Title

      Sci Rep.

      Volume: 8 Issue: 1 Pages: 13166-13166

    • DOI

      10.1038/s41598-018-31383-9

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07035, KAKENHI-PROJECT-18K08637
  • [Journal Article] Infiltration into the Cancer Tissues2018

    • Author(s)
      Akazawa Y, Suzuki T, Nakatsura T
    • Journal Title

      Gan To Kagaku Ryoho

      Volume: 45 Pages: 227-231

    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] がん免疫療法の歴史と今後の課題2018

    • Author(s)
      清水康弘、鈴木利宙、遠藤格、中面哲也
    • Journal Title

      最新医学

      Volume: 73 Pages: 174-181

    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Journal Article] Cancer Immunotherapy Targeted Glypican-3 or Neoantigens.2018

    • Author(s)
      Shimizu Y, Suzuki T, Yoshikawa T, Tsuchiya N, Sawada Y, Endo I, Nakatsura T.
    • Journal Title

      Cancer Sci.

      Volume: 109(3) Issue: 3 Pages: 531-541

    • DOI

      10.1111/cas.13485

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K19990, KAKENHI-PROJECT-18K08637
  • [Presentation] Simultaneous analysis of TCR repertoire and transcriptome of tumor infiltrating T cells in hepatocellular carcinoma (HCC) by single-cell sequences identified clusters including tumor reactive CTLs with early effector like phenotype2021

    • Author(s)
      鈴木利宙
    • Organizer
      第50回日本免疫学会総会
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Presentation] 個別化ペプチドワクチンの開発を目的としたネオアンチゲン予測とヒトHLA発現マウスによる予測ペプチドの抗原性の評価2021

    • Author(s)
      鈴木 利宙、下村 真菜美、藤浪 紀洋、吉川 聡明、平糠 和志、山田 崇、渡部 典子、三嶋 雄二、中村 徳弘、中面 哲也
    • Organizer
      第18回日本免疫治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Presentation] Development of a novel personalized immunotherapy targeting common cancer antigen, glypican-3 (GPC3).2021

    • Author(s)
      Charneau Jimmy, Suzuki Toshihiro, Kojima Motohiro, Gothoda Naoto, Takahashi Shinichiro, Sugimoto Motokazu, Suzuki Yutaka, Seki Masahide, Shimomura Manami, Kanaseki Takayuki, Nakatsura Tetsuya
    • Organizer
      第18回日本免疫治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Presentation] Analysis of tumor-reactive CTLs and its application to personalized immunotherapy in Hepatobiliary and pancreatic carcinoma2020

    • Author(s)
      Suzuki T, Aazawa Y, Shimizu Y, Yoshikawa T, Kojima M, Gotohda N, Takahashi S, Sugimoto M, Suzuki Y, Seki M, NakatsuraT
    • Organizer
      日本がん免疫学会
    • Data Source
      KAKENHI-PROJECT-18K08637
  • [Presentation] The investigation of personalized immunotherapy targeting neoantigen for Liver, Pancreas, and Biliary tract cancer2018

    • Author(s)
      鈴木利宙、赤澤悠、清水康博、 吉川聡明、小嶋基寛、杉本元一、高橋進一郎、後藤田直人、関真秀、鈴木穣、中面哲也
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-18K08637
  • []

  • 1.  小嶋 基寛 (30338470)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 2.  Abe Ryo (20159453)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 3.  中面 哲也 (30343354)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 12 results
  • 4.  小幡 裕希 (20609408)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 5.  Cabral Horacio (10533911)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  佐藤 守俊 (00323501)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  持田 祐希 (60739134)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  高阪 真路 (00627119)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  吉川 聡明
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi